Skip to main content
. 2022 Jul 14;10(7):1122. doi: 10.3390/vaccines10071122

Figure 1.

Figure 1

Comparison of (a) neutralising antibody level and (b) seroconversion rate between antibiotic users and non-users among BNT162b2 recipients. Note: 316 subjects had neutralising antibody level measured at day 21, 284 subjects at day 56, 185 subjects at day 180.